Review





Similar Products

94
MedChemExpress human mce cat
Human Mce Cat, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/FGF-1%2C+Human/pm42599803-266-24-25
Average 94 stars, based on 1 article reviews
human mce cat - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec fgf1
In vitro -derived tanycytes map to the b2 subtype and respond to <t>FGF1</t> (A–C) (A) Integration of day 16 data with “tanycytes” cluster from days 25 and 50 + 70 datasets, (B) annotated clusters, and (C) pseudotime trajectory (monocle 3), (1) indicates trajectory root. (D) Gene expression dynamics of selected markers of dotted outline from (C) along pseudotime. (E) Feature plots of key tanycyte markers. (F) Mapping spatial location of the days 50 + 70 tanycyte cluster onto spatial transcriptomic reference of human hypothalamus. (G) ICC on 2D ARC, scale bar: 25 μm. (H) ICC/ISH on xenografts, scale bars: 50 μm. (I) Volcano plot of DEG in tanycytes after 30min stimulation of 50 ng/mL FGF1 in days 50 + 70 cultures ( n = 3 each, RC17). Benjamini-Hochberg corrected p values. (J) DE of EGR1 and FOS across annotated cell types. Significant upregulation in tanycytes shown in red.
Fgf1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Human+FGF-1%2C+research+grade/pmc13353052-65-0-4
Average 93 stars, based on 1 article reviews
fgf1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc fgfr1
In vitro -derived tanycytes map to the b2 subtype and respond to <t>FGF1</t> (A–C) (A) Integration of day 16 data with “tanycytes” cluster from days 25 and 50 + 70 datasets, (B) annotated clusters, and (C) pseudotime trajectory (monocle 3), (1) indicates trajectory root. (D) Gene expression dynamics of selected markers of dotted outline from (C) along pseudotime. (E) Feature plots of key tanycyte markers. (F) Mapping spatial location of the days 50 + 70 tanycyte cluster onto spatial transcriptomic reference of human hypothalamus. (G) ICC on 2D ARC, scale bar: 25 μm. (H) ICC/ISH on xenografts, scale bars: 50 μm. (I) Volcano plot of DEG in tanycytes after 30min stimulation of 50 ng/mL FGF1 in days 50 + 70 cultures ( n = 3 each, RC17). Benjamini-Hochberg corrected p values. (J) DE of EGR1 and FOS across annotated cell types. Significant upregulation in tanycytes shown in red.
Fgfr1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/FGF+Receptor+1+XP+Rabbit+mAb/pm42849824-144-3-4
Average 96 stars, based on 1 article reviews
fgfr1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc p fgfr1 tyr653 654
In vitro -derived tanycytes map to the b2 subtype and respond to <t>FGF1</t> (A–C) (A) Integration of day 16 data with “tanycytes” cluster from days 25 and 50 + 70 datasets, (B) annotated clusters, and (C) pseudotime trajectory (monocle 3), (1) indicates trajectory root. (D) Gene expression dynamics of selected markers of dotted outline from (C) along pseudotime. (E) Feature plots of key tanycyte markers. (F) Mapping spatial location of the days 50 + 70 tanycyte cluster onto spatial transcriptomic reference of human hypothalamus. (G) ICC on 2D ARC, scale bar: 25 μm. (H) ICC/ISH on xenografts, scale bars: 50 μm. (I) Volcano plot of DEG in tanycytes after 30min stimulation of 50 ng/mL FGF1 in days 50 + 70 cultures ( n = 3 each, RC17). Benjamini-Hochberg corrected p values. (J) DE of EGR1 and FOS across annotated cell types. Significant upregulation in tanycytes shown in red.
P Fgfr1 Tyr653 654, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Phospho-FGF+Receptor+1+(Tyr653%2F654)+Rabbit+mAb/pm42849824-144-6-8
Average 94 stars, based on 1 article reviews
p fgfr1 tyr653 654 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
RayBiotech inc fgf 21
Circulating biomarkers levels in chronic heart failure patients and controls
Fgf 21, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Human+FGF-21+ELISA/pmc13650993-96-6-12
Average 94 stars, based on 1 article reviews
fgf 21 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
MedChemExpress fgf 1
Circulating biomarkers levels in chronic heart failure patients and controls
Fgf 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Animal-Free+TGF+beta+1%2FTGFB1%2C+Mouse%2FRat/pm42599803-300-20-21
Average 94 stars, based on 1 article reviews
fgf 1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Qkine Ltd recombinant fgf 10 qkine qkn qk003 rspondin 1
Circulating biomarkers levels in chronic heart failure patients and controls
Recombinant Fgf 10 Qkine Qkn Qk003 Rspondin 1, supplied by Qkine Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/human+FGF-10/pm42541720-136-8-10
Average 94 stars, based on 1 article reviews
recombinant fgf 10 qkine qkn qk003 rspondin 1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
MedChemExpress primary cortical neurons
Belumosudil inhibits neuronal viability and neurite growth via the AKT signaling pathway. A-B SH-SYSY cells were treated with belumosudil (0, 0.2, 0.5, 1, 2 µM) for 24 h. Cell viability was measured by LDH release assay ( A ) and CCK8 assay ( B ). n = 3, *** P < 0.001, ns indicates no significant difference, one-way ANOVA followed by Dunnett’s multiple comparisons test. C Molecular docking analysis showing the interaction between Belumosudil and AKT1. D-E SH-SYSY cells were treated with 1 µM belumosudil for 0.5 and 1 h. The protein levels of p-AKT (Ser 473), p-GSK3β (Ser 9), AKT were analyzed by Western blot ( D ), and the quantification of the intensities of p-AKT relative to AKT are shown ( E ). n = 3, *** P < 0.001, one-way ANOVA followed by Dunnett’s multiple comparisons test. ( F-G ) Primary cortical neurons were treated with PBS or 100 ng/mL <t>FGF1</t> for 1 days, followed by 1 µM belumosudil for 3 days. Representative MAP2 immunofluorescence images ( F ), and the relative fluorescence intensity of MAP2 was quantified ( G ). n = 3, ** P < 0.01, *** P < 0.001, one-way ANOVA followed by Dunnett’s multiple comparisons test
Primary Cortical Neurons, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/FGF-1%2C+Human/pmc13688901-115-3-13
Average 93 stars, based on 1 article reviews
primary cortical neurons - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc anti p fgfr1
List of primary antibodies, secondary antibodies, and nuclear dyes used in this study.
Anti P Fgfr1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Phospho-FGF+Receptor+1+(Tyr653%2F654)+Rabbit+mAb/pmc13655037-3-0-7
Average 94 stars, based on 1 article reviews
anti p fgfr1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Miltenyi Biotec 1 bfgf
List of primary antibodies, secondary antibodies, and nuclear dyes used in this study.
1 Bfgf, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Human+FGF-2%2C+premium+grade/pmc13391360-419-34-36
Average 95 stars, based on 1 article reviews
1 bfgf - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

Image Search Results


In vitro -derived tanycytes map to the b2 subtype and respond to FGF1 (A–C) (A) Integration of day 16 data with “tanycytes” cluster from days 25 and 50 + 70 datasets, (B) annotated clusters, and (C) pseudotime trajectory (monocle 3), (1) indicates trajectory root. (D) Gene expression dynamics of selected markers of dotted outline from (C) along pseudotime. (E) Feature plots of key tanycyte markers. (F) Mapping spatial location of the days 50 + 70 tanycyte cluster onto spatial transcriptomic reference of human hypothalamus. (G) ICC on 2D ARC, scale bar: 25 μm. (H) ICC/ISH on xenografts, scale bars: 50 μm. (I) Volcano plot of DEG in tanycytes after 30min stimulation of 50 ng/mL FGF1 in days 50 + 70 cultures ( n = 3 each, RC17). Benjamini-Hochberg corrected p values. (J) DE of EGR1 and FOS across annotated cell types. Significant upregulation in tanycytes shown in red.

Journal: Cell Stem Cell

Article Title: Generation of human appetite-regulating neurons and tanycytes from pluripotent stem cells

doi: 10.1016/j.stem.2026.05.005

Figure Lengend Snippet: In vitro -derived tanycytes map to the b2 subtype and respond to FGF1 (A–C) (A) Integration of day 16 data with “tanycytes” cluster from days 25 and 50 + 70 datasets, (B) annotated clusters, and (C) pseudotime trajectory (monocle 3), (1) indicates trajectory root. (D) Gene expression dynamics of selected markers of dotted outline from (C) along pseudotime. (E) Feature plots of key tanycyte markers. (F) Mapping spatial location of the days 50 + 70 tanycyte cluster onto spatial transcriptomic reference of human hypothalamus. (G) ICC on 2D ARC, scale bar: 25 μm. (H) ICC/ISH on xenografts, scale bars: 50 μm. (I) Volcano plot of DEG in tanycytes after 30min stimulation of 50 ng/mL FGF1 in days 50 + 70 cultures ( n = 3 each, RC17). Benjamini-Hochberg corrected p values. (J) DE of EGR1 and FOS across annotated cell types. Significant upregulation in tanycytes shown in red.

Article Snippet: FGF1 (recombinant human) , Miltenyi Biotec , Cat#130-095-789.

Techniques: In Vitro, Derivative Assay, Gene Expression

Circulating biomarkers levels in chronic heart failure patients and controls

Journal: ESC Heart Failure

Article Title: Integrated miRNA-cytokine profiling reveals a molecular signature of cachexia in patients with chronic heart failure

doi: 10.1093/eschf/xvag229

Figure Lengend Snippet: Circulating biomarkers levels in chronic heart failure patients and controls

Article Snippet: Serum concentrations of GDF-15 (#ELH-GDF15-1) and FGF-21 (#ELH-FGF21-1) were measured using ELISA (RayBiotech, Norcross, GA, USA) according to manufacturers’ instructions.

Techniques:

Circulating miRNAs and cytokines as molecular signatures of heart failure. Differences in serum levels of GDF-15 and FGF-21 in CHF patients and controls. Serum levels of GDF-15 by ELISA assay in patients with heart failure (HF) ( n = 25) and the control group ( n = 10). ( A ) Data showed significant upregulation of GDF-15 in CHF vs controls ( P < .001). ( B ) FGF-21 levels did not differ significantly between groups. Correlations between GDF-15 and selected miRNAs in CHF patients. ( C , D ) In CHF patients, GDF-15 levels were positively associated with miR-29b ( ρ = 0.42, P = .037) and miR-486 ( ρ = 0.42, P = .039). Data are expressed as fold change and are presented as mean ± SEM. Student's t -test or Mann–Whitney test was used for normally distributed data or non-normally distributed data, respectively. *** P ≤ .001.

Journal: ESC Heart Failure

Article Title: Integrated miRNA-cytokine profiling reveals a molecular signature of cachexia in patients with chronic heart failure

doi: 10.1093/eschf/xvag229

Figure Lengend Snippet: Circulating miRNAs and cytokines as molecular signatures of heart failure. Differences in serum levels of GDF-15 and FGF-21 in CHF patients and controls. Serum levels of GDF-15 by ELISA assay in patients with heart failure (HF) ( n = 25) and the control group ( n = 10). ( A ) Data showed significant upregulation of GDF-15 in CHF vs controls ( P < .001). ( B ) FGF-21 levels did not differ significantly between groups. Correlations between GDF-15 and selected miRNAs in CHF patients. ( C , D ) In CHF patients, GDF-15 levels were positively associated with miR-29b ( ρ = 0.42, P = .037) and miR-486 ( ρ = 0.42, P = .039). Data are expressed as fold change and are presented as mean ± SEM. Student's t -test or Mann–Whitney test was used for normally distributed data or non-normally distributed data, respectively. *** P ≤ .001.

Article Snippet: Serum concentrations of GDF-15 (#ELH-GDF15-1) and FGF-21 (#ELH-FGF21-1) were measured using ELISA (RayBiotech, Norcross, GA, USA) according to manufacturers’ instructions.

Techniques: Enzyme-linked Immunosorbent Assay, Control, MANN-WHITNEY

Molecular profiles in CHF patients. Differences in serum levels of GDF-15 and FGF-21 among heart failure patients with and without cardiac cachexia. Circulating levels of GDF-15 and FGF-21 were analyzed in CHF patients with cardiac cachexia (CC) ( n = 10) and without cardiac cachexia (nCC) ( n = 15), and a control group ( n = 10). ( A ) Significant difference in GDF-15 levels was observed between patients with CC or nCC vs controls (all P < .001). ( B ) Levels of FGF-21 were significantly higher in CHF with CC compared with nCC ( P = .012) and vs controls ( P = .010) ( C ). Spearman’s correlation analysis revealed that in CHF patients with CC, GDF-15 negatively correlated with miR-21 ( ρ = −0.81, P = .007). ( D ) In the same group, FGF-21 negatively correlated with miR-486 ( ρ = −0.69, P = .035). Data are expressed as fold change and are presented as mean ± SEM. One-way ANOVA test or Kruskal–Wallis test was used for normally distributed data or non-normally distributed data, respectively. * P < .05, *** P ≤ .001.

Journal: ESC Heart Failure

Article Title: Integrated miRNA-cytokine profiling reveals a molecular signature of cachexia in patients with chronic heart failure

doi: 10.1093/eschf/xvag229

Figure Lengend Snippet: Molecular profiles in CHF patients. Differences in serum levels of GDF-15 and FGF-21 among heart failure patients with and without cardiac cachexia. Circulating levels of GDF-15 and FGF-21 were analyzed in CHF patients with cardiac cachexia (CC) ( n = 10) and without cardiac cachexia (nCC) ( n = 15), and a control group ( n = 10). ( A ) Significant difference in GDF-15 levels was observed between patients with CC or nCC vs controls (all P < .001). ( B ) Levels of FGF-21 were significantly higher in CHF with CC compared with nCC ( P = .012) and vs controls ( P = .010) ( C ). Spearman’s correlation analysis revealed that in CHF patients with CC, GDF-15 negatively correlated with miR-21 ( ρ = −0.81, P = .007). ( D ) In the same group, FGF-21 negatively correlated with miR-486 ( ρ = −0.69, P = .035). Data are expressed as fold change and are presented as mean ± SEM. One-way ANOVA test or Kruskal–Wallis test was used for normally distributed data or non-normally distributed data, respectively. * P < .05, *** P ≤ .001.

Article Snippet: Serum concentrations of GDF-15 (#ELH-GDF15-1) and FGF-21 (#ELH-FGF21-1) were measured using ELISA (RayBiotech, Norcross, GA, USA) according to manufacturers’ instructions.

Techniques: Control, Analysis

Molecular profiles in cachectic patients with severe CHF. FGF-21 concentrations and their associations with NYHA functional class in patients with CHF. ( A ) Data show higher FGF-21 levels in NYHA class III-IV ( n = 13) compared with class I-II ( n = 9) ( P = .050) and the control group ( n = 10) ( P = .050). ( B ) In NYHA class III-IV, FGF-21 positively correlated with miR-15b ( r = 0.68, P = .014). Data are expressed as fold change and are presented as mean ± SEM. One-way ANOVA test or Kruskal–Wallis test was used for normally distributed data or non-normally distributed data, respectively. * P < .05.

Journal: ESC Heart Failure

Article Title: Integrated miRNA-cytokine profiling reveals a molecular signature of cachexia in patients with chronic heart failure

doi: 10.1093/eschf/xvag229

Figure Lengend Snippet: Molecular profiles in cachectic patients with severe CHF. FGF-21 concentrations and their associations with NYHA functional class in patients with CHF. ( A ) Data show higher FGF-21 levels in NYHA class III-IV ( n = 13) compared with class I-II ( n = 9) ( P = .050) and the control group ( n = 10) ( P = .050). ( B ) In NYHA class III-IV, FGF-21 positively correlated with miR-15b ( r = 0.68, P = .014). Data are expressed as fold change and are presented as mean ± SEM. One-way ANOVA test or Kruskal–Wallis test was used for normally distributed data or non-normally distributed data, respectively. * P < .05.

Article Snippet: Serum concentrations of GDF-15 (#ELH-GDF15-1) and FGF-21 (#ELH-FGF21-1) were measured using ELISA (RayBiotech, Norcross, GA, USA) according to manufacturers’ instructions.

Techniques: Functional Assay, Control

Schematic representation of the circulating molecular profile associated with chronic heart failure and cardiac cachexia, characterized by dysregulation of muscle- and remodelling-related miRNAs and increased stress-responsive cytokines. CHF patients showed reduced miR-15b, miR-29b, miR-133a, and miR-486 and increased GDF-15, while cardiac cachexia was further associated with lower miR-29b and higher FGF-21 levels.

Journal: ESC Heart Failure

Article Title: Integrated miRNA-cytokine profiling reveals a molecular signature of cachexia in patients with chronic heart failure

doi: 10.1093/eschf/xvag229

Figure Lengend Snippet: Schematic representation of the circulating molecular profile associated with chronic heart failure and cardiac cachexia, characterized by dysregulation of muscle- and remodelling-related miRNAs and increased stress-responsive cytokines. CHF patients showed reduced miR-15b, miR-29b, miR-133a, and miR-486 and increased GDF-15, while cardiac cachexia was further associated with lower miR-29b and higher FGF-21 levels.

Article Snippet: Serum concentrations of GDF-15 (#ELH-GDF15-1) and FGF-21 (#ELH-FGF21-1) were measured using ELISA (RayBiotech, Norcross, GA, USA) according to manufacturers’ instructions.

Techniques:

Belumosudil inhibits neuronal viability and neurite growth via the AKT signaling pathway. A-B SH-SYSY cells were treated with belumosudil (0, 0.2, 0.5, 1, 2 µM) for 24 h. Cell viability was measured by LDH release assay ( A ) and CCK8 assay ( B ). n = 3, *** P < 0.001, ns indicates no significant difference, one-way ANOVA followed by Dunnett’s multiple comparisons test. C Molecular docking analysis showing the interaction between Belumosudil and AKT1. D-E SH-SYSY cells were treated with 1 µM belumosudil for 0.5 and 1 h. The protein levels of p-AKT (Ser 473), p-GSK3β (Ser 9), AKT were analyzed by Western blot ( D ), and the quantification of the intensities of p-AKT relative to AKT are shown ( E ). n = 3, *** P < 0.001, one-way ANOVA followed by Dunnett’s multiple comparisons test. ( F-G ) Primary cortical neurons were treated with PBS or 100 ng/mL FGF1 for 1 days, followed by 1 µM belumosudil for 3 days. Representative MAP2 immunofluorescence images ( F ), and the relative fluorescence intensity of MAP2 was quantified ( G ). n = 3, ** P < 0.01, *** P < 0.001, one-way ANOVA followed by Dunnett’s multiple comparisons test

Journal: BMC Neurology

Article Title: Belumosudil-associated neurological adverse events: evidence from FAERS and experimental validation

doi: 10.1186/s12883-026-05032-y

Figure Lengend Snippet: Belumosudil inhibits neuronal viability and neurite growth via the AKT signaling pathway. A-B SH-SYSY cells were treated with belumosudil (0, 0.2, 0.5, 1, 2 µM) for 24 h. Cell viability was measured by LDH release assay ( A ) and CCK8 assay ( B ). n = 3, *** P < 0.001, ns indicates no significant difference, one-way ANOVA followed by Dunnett’s multiple comparisons test. C Molecular docking analysis showing the interaction between Belumosudil and AKT1. D-E SH-SYSY cells were treated with 1 µM belumosudil for 0.5 and 1 h. The protein levels of p-AKT (Ser 473), p-GSK3β (Ser 9), AKT were analyzed by Western blot ( D ), and the quantification of the intensities of p-AKT relative to AKT are shown ( E ). n = 3, *** P < 0.001, one-way ANOVA followed by Dunnett’s multiple comparisons test. ( F-G ) Primary cortical neurons were treated with PBS or 100 ng/mL FGF1 for 1 days, followed by 1 µM belumosudil for 3 days. Representative MAP2 immunofluorescence images ( F ), and the relative fluorescence intensity of MAP2 was quantified ( G ). n = 3, ** P < 0.01, *** P < 0.001, one-way ANOVA followed by Dunnett’s multiple comparisons test

Article Snippet: For experimental treatments, primary cortical neurons were exposed to belumosudil or FGF1 (HY-P7001, MedChemExpress, USA) for 3 days, beginning on Day 3 in culture.

Techniques: Lactate Dehydrogenase Assay, CCK-8 Assay, Docking Assay, Analysis, Western Blot, Immunofluorescence, Fluorescence

List of primary antibodies, secondary antibodies, and nuclear dyes used in this study.

Journal: Cell Death & Disease

Article Title: Dual-faced metabolic reprogramming powers proliferation: FGF21 drives lung squamous carcinoma progression via CaMKII-DRP1-mediated mitochondrial fission

doi: 10.1038/s41419-026-09084-3

Figure Lengend Snippet: List of primary antibodies, secondary antibodies, and nuclear dyes used in this study.

Article Snippet: Anti-p-FGFR1 (Tyr653/654) , 52928 , Rabbit , CST , WB (1:1000).

Techniques: